delayed gastric emptying glp 1 Autonomic Neuropathy in Diabetes On a GLP-1? Don't cancel
Description
However, the adage that there is no such thing as a free lunch remains true
Healio | Endocrine Today asked members of the Editorial Board and other experts their opinion on the leading topics in endocrinology heading into 2025
Pfizer decided to scrap its trial of danuglipron, an experimental oral GLP-1 agonist, after the once-daily drug caused liver injury in a phase 3 trial participant
CagriSema targets 20%+ and retatrutide targets 24%+
Singh K et al
A., Tulchinsky, D
